![](/img/cover-not-exists.png)
A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer
Athanasios G. Pallis, Alexandra Voutsina, Nikolaos Kentepozidis, Stylianos Giassas, Pavlos Papakotoulas, Sofia Agelaki, Kostas Tryfonidis, Athanasios Kotsakis, Lambros Vamvakas, Nikolaos Vardakis, VasVolume:
13
Year:
2012
Language:
english
Pages:
7
DOI:
10.1016/j.cllc.2011.08.004
File:
PDF, 374 KB
english, 2012